IL-6 Is Not Significantly Associated with Quality of Life Symptoms in Allogeneic Hematopoietic Cell Transplant Recipients Following Tocilizumab
2019 ◽
Vol 25
(3)
◽
pp. S145
2016 ◽
Vol 22
(3)
◽
pp. S191
2019 ◽
Vol 57
(5)
◽
pp. 952-960.e1
◽
2014 ◽
Vol 20
(2)
◽
pp. S101
Keyword(s):
2018 ◽
Vol 24
(11)
◽
pp. 2271-2276
◽
2018 ◽
Vol 53
(5)
◽
pp. 535-555
◽
2013 ◽
Vol 19
(2)
◽
pp. S215
2013 ◽
Vol 49
(2)
◽
pp. 299-303
◽